Multimodality imaging of hypoxia in preclinical settings

R. P. Mason, D. Zhao, J. Pacheco-Torres, W. Cui, V. D. Kodibagkar, P. K. Gulaka, G. Hao, P. Thorpe, E. W. Hahn, P. Peschke

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Hypoxia has long been recognized to influence solid tumor response to therapy. Increasingly, hypoxia has also been implicated in tumor aggressiveness, including growth, development and metastatic potential. Thus, there is a fundamental, as well as a clinical interest, in assessing in situ tumor hypoxia. This review will examine diverse approaches focusing on the preclinical setting, particularly, in rodents. The strategies are inevitably a compromise in terms of sensitivity, precision, temporal and spatial resolution, as well as cost, feasibility, ease and robustness of implementation. We will review capabilities of multiple modalities and examine what makes them particularly suitable for investigating specific aspects of tumor pathophysiology. Current approaches range from nuclear imaging to magnetic resonance and optical, with varying degrees of invasiveness and ability to examine spatial heterogeneity, as well as dynamic response to interventions. Ideally, measurements would be non-invasive, exploiting endogenous reporters to reveal quantitatively local oxygen tension dynamics. A primary focus of this review is magnetic resonance imaging (MRI) based techniques, such as 19F MRI oximetry, which reveals not only hypoxia in vivo, but more significantly, spatial distribution of pO2 quantitatively, with a precision relevant to radiobiology. It should be noted that preclinical methods may have very different criteria for acceptance, as compared with potential investigations for prognostic radiology or predictive biomarkers suitable for use in patients.

Original languageEnglish (US)
Pages (from-to)259-280
Number of pages22
JournalQuarterly Journal of Nuclear Medicine and Molecular Imaging
Volume54
Issue number3
StatePublished - Jun 2010

Fingerprint

Magnetic Resonance Imaging
Radiobiology
Neoplasms
Oximetry
Growth and Development
Radiology
Rodentia
Biomarkers
Oxygen
Costs and Cost Analysis
Hypoxia
Therapeutics
Tumor Hypoxia

Keywords

  • Cell hypoxia
  • Hexafluorobenzene
  • Magnetic resonance imaging
  • Neoplasms
  • Oxygen

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Mason, R. P., Zhao, D., Pacheco-Torres, J., Cui, W., Kodibagkar, V. D., Gulaka, P. K., ... Peschke, P. (2010). Multimodality imaging of hypoxia in preclinical settings. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 54(3), 259-280.

Multimodality imaging of hypoxia in preclinical settings. / Mason, R. P.; Zhao, D.; Pacheco-Torres, J.; Cui, W.; Kodibagkar, V. D.; Gulaka, P. K.; Hao, G.; Thorpe, P.; Hahn, E. W.; Peschke, P.

In: Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 54, No. 3, 06.2010, p. 259-280.

Research output: Contribution to journalArticle

Mason, RP, Zhao, D, Pacheco-Torres, J, Cui, W, Kodibagkar, VD, Gulaka, PK, Hao, G, Thorpe, P, Hahn, EW & Peschke, P 2010, 'Multimodality imaging of hypoxia in preclinical settings', Quarterly Journal of Nuclear Medicine and Molecular Imaging, vol. 54, no. 3, pp. 259-280.
Mason RP, Zhao D, Pacheco-Torres J, Cui W, Kodibagkar VD, Gulaka PK et al. Multimodality imaging of hypoxia in preclinical settings. Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2010 Jun;54(3):259-280.
Mason, R. P. ; Zhao, D. ; Pacheco-Torres, J. ; Cui, W. ; Kodibagkar, V. D. ; Gulaka, P. K. ; Hao, G. ; Thorpe, P. ; Hahn, E. W. ; Peschke, P. / Multimodality imaging of hypoxia in preclinical settings. In: Quarterly Journal of Nuclear Medicine and Molecular Imaging. 2010 ; Vol. 54, No. 3. pp. 259-280.
@article{0321c36fcf0f4be094ccdb1c3f652c47,
title = "Multimodality imaging of hypoxia in preclinical settings",
abstract = "Hypoxia has long been recognized to influence solid tumor response to therapy. Increasingly, hypoxia has also been implicated in tumor aggressiveness, including growth, development and metastatic potential. Thus, there is a fundamental, as well as a clinical interest, in assessing in situ tumor hypoxia. This review will examine diverse approaches focusing on the preclinical setting, particularly, in rodents. The strategies are inevitably a compromise in terms of sensitivity, precision, temporal and spatial resolution, as well as cost, feasibility, ease and robustness of implementation. We will review capabilities of multiple modalities and examine what makes them particularly suitable for investigating specific aspects of tumor pathophysiology. Current approaches range from nuclear imaging to magnetic resonance and optical, with varying degrees of invasiveness and ability to examine spatial heterogeneity, as well as dynamic response to interventions. Ideally, measurements would be non-invasive, exploiting endogenous reporters to reveal quantitatively local oxygen tension dynamics. A primary focus of this review is magnetic resonance imaging (MRI) based techniques, such as 19F MRI oximetry, which reveals not only hypoxia in vivo, but more significantly, spatial distribution of pO2 quantitatively, with a precision relevant to radiobiology. It should be noted that preclinical methods may have very different criteria for acceptance, as compared with potential investigations for prognostic radiology or predictive biomarkers suitable for use in patients.",
keywords = "Cell hypoxia, Hexafluorobenzene, Magnetic resonance imaging, Neoplasms, Oxygen",
author = "Mason, {R. P.} and D. Zhao and J. Pacheco-Torres and W. Cui and Kodibagkar, {V. D.} and Gulaka, {P. K.} and G. Hao and P. Thorpe and Hahn, {E. W.} and P. Peschke",
year = "2010",
month = "6",
language = "English (US)",
volume = "54",
pages = "259--280",
journal = "Quarterly Journal of Nuclear Medicine and Molecular Imaging",
issn = "1824-4785",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "3",

}

TY - JOUR

T1 - Multimodality imaging of hypoxia in preclinical settings

AU - Mason, R. P.

AU - Zhao, D.

AU - Pacheco-Torres, J.

AU - Cui, W.

AU - Kodibagkar, V. D.

AU - Gulaka, P. K.

AU - Hao, G.

AU - Thorpe, P.

AU - Hahn, E. W.

AU - Peschke, P.

PY - 2010/6

Y1 - 2010/6

N2 - Hypoxia has long been recognized to influence solid tumor response to therapy. Increasingly, hypoxia has also been implicated in tumor aggressiveness, including growth, development and metastatic potential. Thus, there is a fundamental, as well as a clinical interest, in assessing in situ tumor hypoxia. This review will examine diverse approaches focusing on the preclinical setting, particularly, in rodents. The strategies are inevitably a compromise in terms of sensitivity, precision, temporal and spatial resolution, as well as cost, feasibility, ease and robustness of implementation. We will review capabilities of multiple modalities and examine what makes them particularly suitable for investigating specific aspects of tumor pathophysiology. Current approaches range from nuclear imaging to magnetic resonance and optical, with varying degrees of invasiveness and ability to examine spatial heterogeneity, as well as dynamic response to interventions. Ideally, measurements would be non-invasive, exploiting endogenous reporters to reveal quantitatively local oxygen tension dynamics. A primary focus of this review is magnetic resonance imaging (MRI) based techniques, such as 19F MRI oximetry, which reveals not only hypoxia in vivo, but more significantly, spatial distribution of pO2 quantitatively, with a precision relevant to radiobiology. It should be noted that preclinical methods may have very different criteria for acceptance, as compared with potential investigations for prognostic radiology or predictive biomarkers suitable for use in patients.

AB - Hypoxia has long been recognized to influence solid tumor response to therapy. Increasingly, hypoxia has also been implicated in tumor aggressiveness, including growth, development and metastatic potential. Thus, there is a fundamental, as well as a clinical interest, in assessing in situ tumor hypoxia. This review will examine diverse approaches focusing on the preclinical setting, particularly, in rodents. The strategies are inevitably a compromise in terms of sensitivity, precision, temporal and spatial resolution, as well as cost, feasibility, ease and robustness of implementation. We will review capabilities of multiple modalities and examine what makes them particularly suitable for investigating specific aspects of tumor pathophysiology. Current approaches range from nuclear imaging to magnetic resonance and optical, with varying degrees of invasiveness and ability to examine spatial heterogeneity, as well as dynamic response to interventions. Ideally, measurements would be non-invasive, exploiting endogenous reporters to reveal quantitatively local oxygen tension dynamics. A primary focus of this review is magnetic resonance imaging (MRI) based techniques, such as 19F MRI oximetry, which reveals not only hypoxia in vivo, but more significantly, spatial distribution of pO2 quantitatively, with a precision relevant to radiobiology. It should be noted that preclinical methods may have very different criteria for acceptance, as compared with potential investigations for prognostic radiology or predictive biomarkers suitable for use in patients.

KW - Cell hypoxia

KW - Hexafluorobenzene

KW - Magnetic resonance imaging

KW - Neoplasms

KW - Oxygen

UR - http://www.scopus.com/inward/record.url?scp=77958537523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958537523&partnerID=8YFLogxK

M3 - Article

C2 - 20639813

AN - SCOPUS:77958537523

VL - 54

SP - 259

EP - 280

JO - Quarterly Journal of Nuclear Medicine and Molecular Imaging

JF - Quarterly Journal of Nuclear Medicine and Molecular Imaging

SN - 1824-4785

IS - 3

ER -